Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.
Saved in:
| Title: | Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. |
|---|---|
| Authors: | Perdrizet J; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Santana CFS; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Senna T; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Alexandre RF; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Sini de Almeida R; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil., Spinardi J; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil., Wasserman M; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Apr 03; Vol. 17 (4), pp. 1162-1172. Date of Electronic Publication: 2020 Sep 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32966176 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Perdrizet+J%22">Perdrizet J</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Santana+CFS%22">Santana CFS</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Senna+T%22">Senna T</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Alexandre+RF%22">Alexandre RF</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Sini+de+Almeida+R%22">Sini de Almeida R</searchLink>; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Spinardi+J%22">Spinardi J</searchLink>; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Wasserman+M%22">Wasserman M</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2021 Apr 03; Vol. 17 (4), pp. 1162-1172. <i>Date of Electronic Publication: </i>2020 Sep 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32966176 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/21645515.2020.1809266 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1162 Titles: – TitleFull: Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Perdrizet J – PersonEntity: Name: NameFull: Santana CFS – PersonEntity: Name: NameFull: Senna T – PersonEntity: Name: NameFull: Alexandre RF – PersonEntity: Name: NameFull: Sini de Almeida R – PersonEntity: Name: NameFull: Spinardi J – PersonEntity: Name: NameFull: Wasserman M IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 04 Text: 2021 Apr 03 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2164-554X Numbering: – Type: volume Value: 17 – Type: issue Value: 4 Titles: – TitleFull: Human vaccines & immunotherapeutics Type: main |
| ResultId | 1 |
